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Volume 57, Number 5S Abstracts 27S(4 year mean follow). Stenosis was graded using a combina-
tion of velocities and velocity ratios, including PSVic/
EDVcc, into six groups: 50%-60%, 60%-70%, 70%-80%,
80%-90%, 90%-95% or 95%-99%. Progression or regression
was considered present if there was a change to adjacent
groups that persisted for at least two consecutive visits.
Results: Regression occurred in 43 (3.8%), no change
in 856 (76.4%), progression in 190 (17.0%) and occlusion
in 32 (2.8%) patients. Ipsilateral ischemic event rate was 0%
with regression, 10.3% with no change, 17.4% with
progression and 28.1% with occlusion (c2, P < .001).
The corresponding values for stroke were 0%, 4.7%. 7.9%
and 12.5%, respectively (c2, P ¼ .029).
Using Kaplan-Meier curves, in the subgroup of patients
with stenosis 70-95% the average annual ipsilateral ischemic
event rate was 2.25% in patients with regression or absence
of change and 4.75% in patients with progression (P <
.001; OR, 2.15, 95% CI, 1.44-3.21). The corresponding
values for stroke were 1.12% and 2.50% (P ¼ .025; OR,
2.01, 95% CI, 1.14-3.54). In the subgroup of occlusion
the average annual ipsilateral ischemic event rate was
5.6% and for stroke 2.6%.
In a logistic regression analysis, the severity of the ﬁnal
stenosis (P ¼ .005; OR, 1.28; 95% CI, 1.08-1.53) and
progression (P ¼ .034; OR, 1.47; 95% CI, 1.03-2.10)
were both independent predictors of ipsilateral ischemic
events.
Conclusions: The degree of stenosis and progression
are both associated with the occurrence of ischemic events
and stroke. Progression identiﬁes a group at increased risk
of stroke.
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Objectives: Although level-1 evidence supports
carotid endarterectomy (CEA) for stroke prevention in
patients with asymptomatic severe (>70%) carotid stenosis
(ASCAS), medical therapy has been promulgated by some
as equally effective. The goal of this study is to determine
the natural history of medically treated ASCAS.
Methods: Patients with ASCAS were identiﬁed by
Duplex (index study 2005-06) and included if they were
treated with medical therapy (for comorbidities or patient
preference). Patients were excluded if they had a carotid
intervention within 6 months of the index Duplex. Aspirin
and statin use (including LDL) was recorded for each
patient. The mean follow-up was 52 months. Study
endpoints included: ipsilateral neurologic symptoms (INS)
(stroke/tia) and death.Results: There were 126 carotid arteries in 115pts. 88
(70%) had severe (70%-89%) and 38 (30%) had very severe
(90%-99%) stenoses (VSS). Demographics: age 73.5 years,
5% chronic kidney disease (CKD), 86% were on statins
(28% had LDL <100 mg/dL) and 88% were on aspirin.
31 (25%) patients developed INS during follow-up and
most 23/31 (74%) occurred within 12 months of the initial
DUS; 45% of INS were strokes. The 5-year actuarial
freedom from INS was 70.1%+/5%. Multivariate predic-
tors of INS included: VSS (HR, 3.23; CI, 1.56-6.76; P ¼
.002), CKD (HR, 6.25; CI, 2.05-19.2; P ¼ .001), age
(HR, .94; CI, .91-0.98; P ¼ .001). 41 (33%) patients
underwent eventual carotid revascularization (32 CEA, 9
Stent); 56% were performed for INS and 44% for plaque
progression. The 5-year actuarial survival was 69.8%+/
4.1%. Multivariate predictors of death included: Age
(HR, 1.06; CI, 1.03-1.1; P ¼ .0001), COPD (HR, 1.92;
CI, 1.08-3.41; P ¼ .03) and DM (HR, 5.08; CI, 2.86-
9.01; P < .0001). Neither statin nor aspirin use was protec-
tive in this cohort.
Conclusions: Medically managed patients with
ASCAS develop INS early; especially those with >90%
stenosis. The natural history of medically treated ASCAS
and failure of aspirin/statins to prevent INS supports
the continued role of CEA as ﬁrst line therapy in these
patients.
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Background: To demonstrate a novel and simple
Carotid Endarterectomy technique that results in a shorter
procedure, decreased recovery time, lesser risk of complica-
tions and signiﬁcant cost reduction.
Technical Description: This procedure consists of
a mini arteriotomy (12 to 14 mm long) on the front
wall of the internal carotid’s widest origin “without”
transecting the artery completely as in the classical ever-
sion technique.
Eversion endarterectomy is done from below the bifur-
cation distally into the external and internal simultaneously.
There are several advantages:
a. The back wall of the artery remains intact, therefore
less chances of suture line proliferation or recurrence.
b. Easy to prolong arteriotomy and correct a question-
able distal endpoint (contrary to the standard
complete transection)
c. Avoid prosthetic patch preventing infection, pseudoa-
neurysm, or suture line bleeding
d. Signiﬁcant reduced clamping time
e. Considerable reduction in the cost of OR time, anes-
thesia, PACU, and LOS
